Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349]
Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349]. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126002993?dgcid=rss_sd_all
Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349]. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126002993?dgcid=rss_sd_all
“Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349].” European Urology Oncology.
@article{article45591,
title = {Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349]},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126002993?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...